Johnson & Johnson Joins Forces with the Foundation for Peripheral Neuropathy as 2024 Impact Partner

The Foundation for Peripheral Neuropathy (FPN) is proud to announce an exciting new partnership with Johnson & Johnson, one of the world’s leading healthcare companies, as an esteemed 2024 Ambassador Impact Partner. This collaboration marks a significant milestone in FPN’s mission to advance research and education for individuals affected by peripheral neuropathy (PN).

Collaboration for Impact

At FPN, our commitment to improving the lives of those living with peripheral neuropathy is unwavering. From advocating for increased awareness to funding groundbreaking research, we strive to make meaningful progress in understanding and treating this complex condition. By joining forces with Johnson & Johnson, we are bolstering our efforts to provide support and resources to individuals living with this condition and their families and caregivers. 

Peripheral neuropathy impacts millions of people worldwide, causing symptoms such as numbness, tingling, and pain in the extremities. It can be debilitating, impacting daily activities, and diminishing quality of life. Johnson & Johnson shares our dedication to enhancing patient care and improving health outcomes. Through their innovative research, cutting-edge technologies, and commitment to community engagement, they have demonstrated a profound understanding of the challenges faced by individuals with peripheral neuropathy. Together, we will leverage our collective expertise and resources to drive advancements in diagnosis, treatment, and ultimately, finding cures. 

As we embark on this journey together, we extend our heartfelt gratitude to Johnson & Johnson for their unwavering support and commitment to our shared mission. We are changing lives and shaping a brighter future for generations to come.

About the Foundation for Peripheral Neuropathy (FPN):

The Foundation for Peripheral Neuropathy is a non-profit organization dedicated to improving the lives of individuals affected by peripheral neuropathy through awareness, research, advocacy, and education. FPN strives to increase awareness of peripheral neuropathy, provide resources for patients and caregivers, and fund innovative research to advance the understanding and treatment of this condition. To learn more, visit www.foundationforpn.org. Interested in partnering with FPN? Email [email protected].

About Johnson & Johnson:

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/ or at https://www.janssen.com/johnson-johnson-innovative-medicine. Follow us at @JanssenUS and @JNJInnovMed.

Leave a Comment